V
Vir Biotechnology D
D
VIR
5.51000
USD
-0.14
(-2.48%)
مفتوح الان
حجم التداول
31,276
الربح لكل سهم
-2
العائد الربحي
-
P/E
-1
حجم السوق
761,691,397
الأخبار المقالات
العنوان: Vir Biotechnology
القطاع: Healthcare
الصناعة: Biotechnology
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development,collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.